Find your next paid study

Alnylam PharmaceuticalsNCT06679946

~$50 – $2,100

Actual pay is set by the research site.

Primary Central Nervous System LymphomaRecurrent CancerRefractory Cancer+1 more

A Phase Ib/II Study of Pembrolizumab, Ibrutinib and Rituximab in Refractory/Relapsed Primary Central Nervous System Lymphoma (PCNSL)

This research study is evaluating a combination therapy of 3 drugs as possible treatments for recurrent primary central nervous system lymphoma (PCNSL). The t…

Dana-Farber Cancer InstituteNCT04421560

~$150 – $4,500

Actual pay is set by the research site.

Phase 2

A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial

Major depressive disorder (MDD) is a significant public health problem and leading cause of worldwide disability. Treatment resistance is common in MDD, howeve…

Treatment Resistant DepressionTreatment Resistant Depression (TRD)

~$75 – $2,800

Actual pay is set by the research site.

NeuroRx, Inc.NCT07227103

A Phase I/II, First-in-Human, Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Preliminary Efficacy, and Immunogenicity of TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.

The goal of this clinical trial is to evaluate whether TJ102, an investigational antibody-drug conjugate (ADC), can safely and effectively treat patients with …

Ovarian Cancer

Phrontline BiopharmaNCT07778498

~$150 – $4,200

Actual pay is set by the research site.

Observational

Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection: A RandomizeD Trial IN Colorectal Adenomas 10-19mm and Serrated Lesions ≥ 10mm (CARDINAL Study)

The study will compare the use of cold snare piecemeal resection (CSPR) vs cold endoscopic mucosal resection (Cold EMR). The study will include two cohorts: on…

Colon PolypColon AdenomaSerrated Polyp

Indiana UniversityNCT06462521

Actual pay is set by the research site.

Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will a…

Hereditary Cancer Syndrome

Columbia UniversityNCT07195071

Actual pay is set by the research site.

Phase 2

Supplementation of Gut-brain Axis (GLP-1)-Activating Carbohydrates for Increasing Satiety in Adolescents With Obesity

Glucagon-like peptide (GLP1) drugs have quickly become a standard treatment for the adults with obesity. These drugs target the appetite control center of the …

Obesity & Overweight

Indiana UniversityNCT07823452

~$75 – $2,000

Actual pay is set by the research site.

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TVB-3567 in Healthy Participants With or Without Acne and to Assess the Effect of Food in Healthy Participants

This is a 4-part study. Part A will be a randomized, double-blind, placebo-controlled investigation of single ascending doses (SAD) to assess the safety, toler…

Acne

Sagimet Biosciences Inc.NCT06989840

~$500 – $10,500

Actual pay is set by the research site.

Observational

Remote vs. In-Person Study Evaluation (RISE) Above Depression

The study will employ a randomized, parallel-group design with two-stage randomization. After an initial brief screen for basic eligibility, participants will …

Remote vs. In-PersonRemote VisitsIn-person Visits

State University of New York at BuffaloNCT07854301

Actual pay is set by the research site.

Cardiovascular Structure and Function in Mucopolysaccharidosis Types I and IVA

The purpose of this study is to better understand how heart and blood vessel problems develop in people with Mucopolysaccharidosis (MPS). The investigators are…

MPS IMPS IV AMPS - Mucopolysaccharidosis+1 more

Children's Hospital of Orange CountyNCT07361536

Actual pay is set by the research site.

Phase 2

A Pilot Study of Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for Upfront Treatment of Aggressive B-Cell Non-Hodgkin Lymphomas

This phase II trial tests the safety, best dose, and effectiveness of epcoritamab when given with etoposide, cyclophosphamide, vincristine, doxorubicin, predni…

B-Cell Non-Hodgkin LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more

~$75 – $2,000

Actual pay is set by the research site.

A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1311 in Subjects With Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1311/BNT324 in subjects with advanced solid tumors.

Advanced Solid Tumors